期刊
NEUROLOGICAL SCIENCES
卷 41, 期 3, 页码 691-694出版社
SPRINGER-VERLAG ITALIA SRL
DOI: 10.1007/s10072-019-04112-x
关键词
TP53 p; R337H mutation; Pediatric ependymoma; RELA fusion; Southern Brazil
资金
- Conselho Nacional de Desenvolvimento Científico e Tecnológico [151760/2018-7, 457884/2014-2] Funding Source: Medline
- Fundação de Amparo à Pesquisa do Estado de São Paulo [2014/20341-0, 2015/03614-5, 2016/19820-6] Funding Source: Medline
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior [001] Funding Source: Medline
Background Ependymoma (EPN) is the third most common childhood cancer of the central nervous system. RELA fusion-positive EPN accounts for approximately 70% of all childhood supratentorial tumors and shows the worst prognosis among the supratentorial EPNs. TP53 mutation is infrequent in RELA fusions EPNs. In the population from the Southern region of Brazil, there is a high incidence of the germline TP53 p.R337H mutation that predisposes carriers to develop early-onset tumors. However, despite this high incidence, the frequency of this mutation among EPN patients remains to be determined. Here, we investigated the presence of the TP53 p.R337H mutation in a larger cohort of pediatric EPNs of three institutions located in the state of Sao Paulo, Brazil. Methods The TP53 p.R337H mutation was screened by conventional RT-PCR and Sanger sequencing in 49 pediatric EPNs diagnosed during the period from 1995 to 2016. Results We described for the first time a case of a 5-year-old girl with RELA fusion EPN with a heterozygous TP53 p.R337H mutation. Conclusions The present finding indicates that the TP53 p.R337H germline mutation is uncommon in patients with EPN in Brazil and screening of pediatric patients RELA fusion EPN may be informative to better understand the role of TP53 germline mutations in the development and prognosis of these tumors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据